About
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
Company Website : http://www.compasspathways.com
Address : 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
Employees : 61
Fiscal Year End : December
Currency: USD
Country : USA
Technical Indicators
52 Week High : 61.69
Short Ratio : 0.95
52 Week Low : 22.51
Shorted Shares : 467,120
200 Day Moving Average : 38.83
Shorted Shares Previous Month : 1,302,567
50 Day Moving Average : 36.07
Shares Held By Insiders : 4.51%
Short Percentage : 1.00%
Shares Held by Institutions : 12.77%
Unadjusted Closing Price
Adjusted Closing Price
Share Volume
Relative Performance (Total Returns)
Compare
Relative Returns (From: To: 2021-08-03 )
Largest Industry Peers for Other
| Symbol | Name | Price(Change) | Market Cap | Price / Earning Ratio | EV/EBITDA |
|---|---|---|---|---|---|
| LGCY | Legacy Reserves Inc |
N/A |
USD61,525,874.67B | 1.10 | 5.30 |
| FTD | FTD Companies, Inc |
N/A |
USD28,725,913.80B | N/A | N/A |
| KEYW | The KeyW Holding Corporation |
N/A |
USD24,651,104.38B | 166.80 | 24.48 |
| SNHY | Helios Technologies, Inc |
N/A |
USD17,848,852.22B | 1,000,000.00 | N/A |
| QTNA | Quantenna Communications, Inc |
N/A |
USD8,997,243.52B | 175.07 | 79.98 |
| INSY | INSYS Therapeutics, Inc |
N/A |
USD4,995,459.82B | 115.90 | N/A |
| CHKE | Apex Global Brands Inc |
N/A |
USD384,202.91B | 17.30 | N/A |
| AMCN | AirNet Technology Inc |
N/A |
USD308,457.30B | 1.00 | N/A |
| PDVW | pdvWireless, Inc |
N/A |
USD95,944.74B | N/A | N/A |
| AIPT | Predictive Oncology Inc |
N/A |
USD38,513.36B | N/A | N/A |
ETFs Containing CMPS
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|
N/A
Market Performance
| Market Performance vs. Industry/Classification (Other) |
Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -30.58% | 17% | F | 12% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -30.58% | 17% | F | 12% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
| Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
| Market Capitalization | 1.45B | 72% | C- | 71% | C- | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 87%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
Key Financial Ratios
| Ratio vs. Industry/Classification (Other) |
Ratio vs. Market |
||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| Market Value | |||||||
| Price / Earning Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Price/Book Ratio | 7.82 | 27% | F | 19% | F | ||
| Price / Cash Flow Ratio | -35.16 | 86% | B | 85% | B | ||
| EV/EBITDA | N/A | N/A | N/A | N/A | N/A | ||
| Management Effectiveness | |||||||
| Return on Equity | -67.93% | 33% | F | 24% | F | ||
| Return on Invested Capital | -54.92% | 24% | F | 15% | F | ||
| Return on Assets | -29.06% | 11% | F | 11% | F | ||
| Debt to Equity Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Technical Ratios | |||||||
| Short Ratio | 0.95 | 71% | C- | 75% | C | ||
| Short Percent | 2.10% | 82% | B- | 61% | D- | ||
| Beta | N/A | N/A | N/A | N/A | N/A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 97%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
Annual Financials (USD)
Quarterly Financials (USD)
Analyst Rating
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
No discussions yet
User / Independent Analyst Ratings
| User Name | Target Rating | Target Horizon (Months) | Target Price | User Analysis | Date | Comment |
|---|
Fundamental Analysis Breakdown
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like:
There is nothing we particularly like
What to not like:
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
